Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01908140 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

933

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Aclidinium Bromide / Formoterol Fumarate
DRUG: Salmeterol / Fluticasone

Sponsor

AstraZeneca